TEL AVIV, Israel, June 15, 2012 /PRNewswire/ -- InspireMD, Inc. (OTC BB: NSPR) (the "Company" or "InspireMD"), a medical device company focusing on the development and commercialization of its proprietary stent platform technology for use in patients with Acute Myocardial Infarctions, announced today that Craig Shore, Chief Financial Officer, will present at the Marcum MicroCap Conference on June 20th in New York City. The event is hosted by Marcum LLP, one of the top ten auditors of U.S. public companies. Presentation Details
Date: Wednesday, June 20, 2012
Location: The Hudson Suite at The Roosevelt Hotel, 45 East 45th Street, New York, NY
Presenting on behalf of InspireMD will be Craig Shore, CFO. About the Marcum Microcap Conference The Marcum MicroCap Conference is dedicated to introducing investors to the very best, undiscovered companies under $500 million in market capitalization. The event is targeted at top fund managers and qualified high net worth investors who focus on small cap equities. More than 500 participants are expected this year, including institutional investors, mutual funds, hedge funds, wealth managers, and family offices. Industries featured include Life Sciences, Technology, Media & Telecom, Social Media & Internet, Consumer, Metals & Mining Industrials and Energy. The conference will also include panel discussions focused on issues that are of key interest to the financial community involved with micro and small-cap growth companies. Marcum LLP is one of the largest independent public accounting and advisory services firms in the U.S.The event is being co-hosted by CCG Investor Relations, a global investor relations consulting firm. The conference is free to attend for qualified investors. For full event details and registration information, please click here: http://www.marcumllp.com/MicroCap About InspireMD, Inc.